Author: Fathi, Anahita; Dahlke, Christine; Addo, Marylyn M.
Title: Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens Document date: 2019_9_5
ID: 4cia91cq_34_1
Snippet: igs did develop signs of disease, but 71% of animals were still protected from death. 106 In recent developments, CEPI furthermore awarded considerable research funds to develop, manufacture and ultimately stockpile a Lassa virus vaccine based on the above mentioned rVSV-N4CT1 platform. 107 While further research including additional studies in NHPs is warranted, the data suggest that VSVΔG/LASVGPC may be a universal vaccine candidate that can c.....
Document: igs did develop signs of disease, but 71% of animals were still protected from death. 106 In recent developments, CEPI furthermore awarded considerable research funds to develop, manufacture and ultimately stockpile a Lassa virus vaccine based on the above mentioned rVSV-N4CT1 platform. 107 While further research including additional studies in NHPs is warranted, the data suggest that VSVΔG/LASVGPC may be a universal vaccine candidate that can confer early and lasting immunity.
Search related documents:
Co phrase search for related documents- additional study and vaccine candidate: 1
- Lassa virus and recent development: 1, 2
- Lassa virus and vaccine candidate: 1, 2, 3
- Lassa virus vaccine and vaccine candidate: 1
Co phrase search for related documents, hyperlinks ordered by date